Pranada Biopharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.00 M
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.85 M
- Revenue Growth -7.71%
- Profit Growth -123.13%
- Ebitda -111.58%
- Net Worth -3.68%
- Total Assets 7.34%
About Pranada Biopharma
Pranada Biopharma Private Limited (PBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 15 March 2014 and has a history of Ten years and 11 months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹8.85 M.
Lalu Joshi, Madhu Dhakan, and Mukesh Gupta serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900MH2014PTC254347
- Company No.
254347
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Mar 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Pranada Biopharma Private Limited offer?
Pranada Biopharma Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services.
Who are the key members and board of directors at Pranada Biopharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lalu Joshi  | Director | 15-Mar-2014 | Current |
| Madhu Dhakan | Director | 26-Feb-2024 | Current |
| Mukesh Gupta | Director | 26-Feb-2024 | Current |
Financial Performance of Pranada Biopharma.
Pranada Biopharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.71% decrease. The company also saw a substantial fall in profitability, with a 123.13% decrease in profit. The company's net worth dipped by a decrease of 3.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pranada Biopharma?
Unlock access to Pranada Biopharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Grushie Energy Private LimitedLalu Joshi is a mutual person
- Pranada Buildcon Private Limited
Lalu Joshi is a mutual person
Charges (Loans)
₹8.85 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.89 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jul 2021 | Axis Bank Limited | ₹2.45 M | Open |
| 23 Aug 2018 | Axis Bank Limited | ₹6.40 M | Open |
How Many Employees Work at Pranada Biopharma?
Unlock and access historical data on people associated with Pranada Biopharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pranada Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pranada Biopharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
